We recently found that silencing of Livin-positive RCC cell lines was linked to a re-sensitisation of the tumour cells towards proapoptotic agents, including chemotherapeutics (Crnković-Mertens et al, 2007). The gene discussed is BIRC7; the disease is neoplasm.